SCHEMBL25820511

SCHEMBL25820511

O=C(Nc1cccc(Nc2ccccn2)c1)c1cccc(Nc2ccnc3ccc(F)cc23)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 5/20 0.60
DNMT3A Q9Y6K1 5/20 0.60
DNMT3L Q9UJW3 4/20 0.57
EHMT1 Q9H9B1 2/20 0.57
CES1 P23141 1/20 0.48
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPK1 P28482 1/20 0.47
CDK8 P49336 2/20 0.47
CCNC P24863 1/20 0.47
KCNK3 O14649 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.46
APEX1 P27695 1/20 0.46
AURKA O14965 1/20 0.46
AURKB Q96GD4 1/20 0.46
CLK2 P49760 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25820567 0.90 DNMT1 (0.63) DNMT1DNMT3ADNMT3LEHMT1CYP1A2
SCHEMBL30290755 0.90 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1CES1
SCHEMBL25820533 0.90 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1CES1
SCHEMBL24011122 0.90 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1CES1
SCHEMBL30290877 0.89 DNMT1 (0.56) DNMT1DNMT3ADNMT3LEHMT1CYP1A2
SCHEMBL24009959 0.89 DNMT1 (0.56) DNMT1DNMT3ADNMT3LEHMT1CYP1A2
SCHEMBL30290866 0.88 DNMT1 (0.59) DNMT1DNMT3ADNMT3LEHMT1CYP1A2
SCHEMBL24010563 0.88 DNMT1 (0.59) DNMT1DNMT3ADNMT3LEHMT1CYP1A2
SCHEMBL25821808 0.86 DNMT1 (0.60) DNMT1DNMT3ADNMT3LEHMT1CYP1A2
SCHEMBL24009914 0.86 DNMT1 (0.60) DNMT1DNMT3ADNMT3LEHMT1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885DNMT3L 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.